Artrya Ltd
ASX:AYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Artrya Ltd
ASX:AYA
|
AU |
|
Pnb Gilts Ltd
NSE:PNBGILTS
|
IN |
|
N
|
New Nordic Healthbrands AB
STO:NNH
|
SE |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
Tokai Senko KK
TSE:3577
|
JP |
|
Hoe Leong Corporation Ltd
SGX:H20
|
SG |
|
E
|
Einhell Germany AG
XETRA:EIN
|
DE |
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
IN |
|
Turkiye Kalkinma ve Yatirim Bankasi AS
IST:KLNMA.E
|
TR |
|
K Car Co Ltd
KRX:381970
|
KR |
|
HM International Holdings Ltd
HKEX:8416
|
HK |
Balance Sheet
Balance Sheet Decomposition
Artrya Ltd
Artrya Ltd
Balance Sheet
Artrya Ltd
| Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
2
|
13
|
15
|
20
|
7
|
11
|
|
| Cash |
1
|
2
|
13
|
15
|
20
|
0
|
11
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
7
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
20
|
0
|
149
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
3
|
4
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
3
|
4
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
1
|
3
|
14
|
38
|
24
|
12
|
17
|
|
| PP&E Net |
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
1
|
4
|
7
|
6
|
5
|
|
| Total Assets |
1
N/A
|
3
+190%
|
15
+468%
|
44
+191%
|
33
-25%
|
19
-43%
|
24
+25%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
2
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+164%
|
1
+621%
|
3
+176%
|
3
-22%
|
2
-13%
|
2
+8%
|
|
| Equity | ||||||||
| Common Stock |
1
|
4
|
18
|
56
|
56
|
56
|
75
|
|
| Retained Earnings |
0
|
1
|
4
|
16
|
26
|
40
|
54
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+192%
|
14
+458%
|
41
+192%
|
31
-25%
|
17
-45%
|
21
+27%
|
|
| Total Liabilities & Equity |
1
N/A
|
3
+190%
|
15
+468%
|
44
+191%
|
33
-25%
|
19
-43%
|
24
+25%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
78
|
78
|
78
|
78
|
79
|
79
|
113
|
|